PRIMARY PERITONEAL CARCINOMA
Clinical trials for PRIMARY PERITONEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CARCINOMA trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat ovarian cancer: drug combo shows promise in early trial
Disease control CompletedThis study tested a new drug called ZN-c3, alone or with another drug (niraparib), in 117 people with ovarian cancer that stopped responding to platinum-based chemotherapy. The goal was to see if the treatment is safe and can shrink tumors or slow the disease. This is not a cure,…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug combo shows promise for Tough-to-Treat ovarian cancer
Disease control CompletedThis early-stage trial tested a new drug called SL-172154 combined with either standard chemotherapy or a targeted therapy in 86 people with ovarian cancer that stopped responding to platinum-based chemo. The main goals were to check safety and find the best dose. Researchers als…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: PHASE1 • Sponsor: Shattuck Labs, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Spit test could track hidden virus in ovarian cancer patients
Knowledge-focused CompletedThis study looked at whether using saliva instead of blood can help monitor cytomegalovirus (CMV) infection in people being treated for ovarian cancer. Researchers collected saliva and blood samples from 49 participants, both in clinic and at home. The goal was to see if remote s…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 04:35 UTC
-
Routine BRCA testing for ovarian cancer: a game changer in the making?
Knowledge-focused CompletedThis study looked at whether it's practical to routinely test tumor tissue from ovarian cancer patients for BRCA gene mutations. Researchers enrolled 200 patients with high-grade serous or endometrioid ovarian, fallopian tube, or primary peritoneal cancer. The goal was to see if …
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Sponsor: Cancer Trials Ireland • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC